VIVES Partners’ Post

🚀 MyriaMeat - a biotech startup founded by a team around researchers from the University of Göttingen, that is revolutionizing the food industry with its patented technology to cultivate 100% real meat from pluripotent stem cells. ✅ With over 25 years of research MyriaMeat is committed to creating sustainable and ethical alternatives to traditional meat products. ✅ Our goal for the future is to create products, that are all-natural without chemical or biological contaminants, offering the healthiest cultivated meat possible. ✅ By aligning meat production with the needs of the growing population while reducing greenhouse gas emissions and addressing the ethical concerns of using animals for meat, we are paving the way for a healthier, more sustainable future. Want to learn more? Get in contact ! www.myriameat.com #MyriaMeat #CultivatedMeat #SustainableFuture #foodtech #EthicalMeat #biotech

🚨Liberset is thrilled to announce its strategic investment in a major European industrial biotechnology leader   Abolis Biotechnologies is a company specializing in industrial solutions using microorganisms and developing bio-production processes of molecules through fermentation. These processes allow the production of sustainable and biodegradable ingredients for the cosmetic, pharma, food, and chemical industries. This funding will fuel the company’s expansion into global markets and accelerate its research and development efforts to bring innovative biomanufacturing and microbiome solutions to the market. Liberset is proud to collaborate closely with Cyrille PAUTHENIER (CEO), Valérie Brunel (General Manager), Gwenael Servant (VP Business & Strategy) as well as the whole Abolis’ team in their future developments, especially in their expansion in North and South America. The chemical sector is facing major problematics as it is the largest industrial energy consumer and the 3rd largest industry subsector in terms of direct CO2 emissions. This is largely because around 50% of the chemical subsector’s energy input is consumed as feedstock (fuel used as a raw material input rather than as a source of energy).   Thus, to solve this complex situation, Abolis Biotechnologies decided to dedicate its mission to the development of green chemical production processes with sustainable supply chains (use of ag. waste, etc.) to find alternatives to legacy petroleum-based chemicals.   We strongly believe in Abolis’ capacity to become a major and global ecological transition player thanks to the support of its new international community of investors. Liberset is happy to join forces with DTCF | DeepTech & Climate Fonds, Evonik, BOLD, Icos Capital & Clay Capital fka VisVires New Protein. Tobias Faupel Cristina Doumitrachko Julie Pelcener Camille Jaegle Muriel ATIAS Tony Khajenouri Frédéric Legrand Dr. Jens Busse Wolfgang Nestel Jan Hahnwald Peter Van Gelderen Wouter van Rooijen Katarzyna (Kasia) Gil Matthieu Vermersch Gerard Chia Celine Ng Darren Leong Damien Bourel Eric Lepleux Bruno Dizengremel Vincent Walczak

The Union Cabinet has recently approved the proposal ‘BioE3 (Biotechnology for Economy, Environment and Employment) Policy for Fostering High Performance Biomanufacturing’ of the Department of Biotechnology. This policy will address the national priorities focusing on the following strategic/thematic sectors: High value bio-based chemicals, Biopolymers & enzymes; Smart proteins & functional foods; Precision biotherapeutics; Climate resilient agriculture; Carbon capture & its utilization; Marine and space research Today (4th Sep 2024) we are organizing an 'Orientation and Discussion Session' on the BioE3 Policy with stakeholders like academia (faculty and students), Bio-Incubators, Bio-innovators and Start-ups at the E-YUVA Centre, Adamas University. The Program is in association with our incubate start-up Gene Prospera Biotech Pvt. Ltd. Let us all strive towards the success of the policy towards Viksit Bharat! Innovation and Incubation -Adamas University | Adamas University | DBT BIRAC Goutam Mukherjee, Dr Mousumi Saha, Dr. Saptarshi Chatterjee, Dr. Rudra P. Saha, Sachchidananda Podder, Nilanjana Mitra #innovation #economy #BIOE3 #entrepreneurship #incubation #skilldevelopment #biotechnology #environment #employment #birac #dbt

As a fellow English major, I loved chatting with Dan Goddard about his unique career path and his current position launching and scaling biotechs at Browne Consulting. It's a great episode - I hope you enjoy it! #biotechcareers #buildingbiotechs #podcasts

Revolutionizing the Bio-Based Sector: Izote Biosciences' Fermentation Breakthrough In the realm of bio-based production, Izote Biosciences is charting a new course with its anaerobic fermentation technology. Co-founded by Victor Manuel Reyes-Umaña, a microbiologist, and Samuel Atwood, a former McKinsey & Company consultant, Izote has successfully closed an oversubscribed pre-seed funding round of $2.6 million, signaling strong market interest in their innovation. 🔬 The Innovation Edge: Izote's method allows bacteria to flourish without oxygen, using a molecule vastly more soluble than oxygen. This not only simplifies bioreactor design but also slashes operational costs, a game-changer for industries reliant on precision fermentation. 💡 Market Transformation: The implications for the fragrance, flavor, food, and cosmetics industries are profound. Izote's technology is set to deliver cost savings and boost gross margins, reshaping the economics of bio-based molecule production. Investment Potential: 💼 Cutting-Edge Appeal: Izote's pioneering approach is a magnet for investors looking to capitalize on the next wave of industrial biotech advancements. 💼 Scalability Meets Savings: With the promise of 70% lower capital expenditures and up to 100% higher gross margins, Izote's technology is poised for rapid market penetration and scalability. 💼 Confirmed Confidence: The success of Izote's pre-seed funding, led by top-tier venture capitalists, is a testament to the market's belief in their disruptive potential. Future Outlook: As Izote sets its sights on identifying launch molecules and proving scalability, the startup is well-positioned for sustainable growth and industry leadership. This is a pivotal moment for stakeholders to engage with a company that's redefining the bio-based product landscape. Stay tuned with Market Unwinded for strategic insights into the burgeoning world of synthetic biology and investment opportunities that redefine market norms. Read More: https://lnkd.in/gT6nHe3T #IzoteBiosciences #SyntheticBiology #BiotechInnovation #VentureCapital #MarketLeadership #SustainableGrowth #MarketUnwinded #InvestmentStrategy #AnaerobicFermentation

Incubators have become a crucial part of life science ecosystems throughout the country. Understanding the impacts on these ecosystems have become crucial to forecasting future demand and growth. CBRE's report on incubators provides a great overview to those interested in learning more. . . . . . . . . . . #cbre #lifescience #incubators #2024 #biotech #lifescienceincubators

Last week's issue had us thinking, how much does a biodesigner want to know about the biotechnology in some of these upcoming innovations? If you would like to dig into more biotechnology and science drop a 🥼 in the comments

Biology promises a more resilient future and #BioE3Policy will lay a strong foundation for #biotech sector. India has emerged as a bio-innovation hub and #BIRAC is playing a key role in fostering startups in the biotechnology sector - Kiran Mazumdar Shaw #GlobaBioIndia2024 #Biotechnology #biotechrevolution

🎙 Would it be a relief to hear from someone who's built biotechs in a down market (2008), and lived to tell the tale? We certainly thought so! Dan Goddard of Browne of Browne Consulting Group told us some great stories: -Navigating the cyclical nature of biotech -Riding the waves of good and bad funding times -Getting creative with capital -Diverse companies do better -Culture and mission are the keys to staying the course Take a listen, and let us know if Dan's advice resonates! #buildingbiotechs #biotechnology #biotechstartup